200 related articles for article (PubMed ID: 22193838)
1. Cost-effectiveness of pharmacologic and invasive therapies for stroke prophylaxis in atrial fibrillation.
Solomon MD; Ullal AJ; Hoang DD; Freeman JV; Heidenreich P; Turakhia MP
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):86-96. PubMed ID: 22193838
[TBL] [Abstract][Full Text] [Related]
2. Stroke prevention in atrial fibrillation.
Mohammed I; Mohmand-Borkowski A; Burke JF; Kowey PR
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):73-85. PubMed ID: 22193836
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarin.
Lee S; Anglade MW; Meng J; Hagstrom K; Kluger J; Coleman CI
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):472-9. PubMed ID: 22740012
[TBL] [Abstract][Full Text] [Related]
4. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation.
Amorosi SL; Armstrong S; Da Deppo L; Garfield S; Stein K
Europace; 2014 Aug; 16(8):1131-6. PubMed ID: 24687964
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation.
Lee VW; Tsai RB; Chow IH; Yan BP; Kaya MG; Park JW; Lam YY
BMC Cardiovasc Disord; 2016 Aug; 16(1):167. PubMed ID: 27581874
[TBL] [Abstract][Full Text] [Related]
6. Left atrial appendage occlusion for the reduction of stroke and embolism in patients with atrial fibrillation.
Gibson DN; Price MJ; Ahern TS; Teirstein PS
J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):131-7. PubMed ID: 22193834
[No Abstract] [Full Text] [Related]
7. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
Shah SV; Gage BF
Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
[TBL] [Abstract][Full Text] [Related]
8. New frontiers for stroke prevention in atrial fibrillation.
Prasad V; Kaplan RM; Passman RS
Cerebrovasc Dis; 2012; 33(3):199-208. PubMed ID: 22261539
[TBL] [Abstract][Full Text] [Related]
9. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
Savelieva I; Bajpai A; Camm AJ
Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation.
Han J; Cheng J; Mathuria N
Pacing Clin Electrophysiol; 2012 Jul; 35(7):887-96. PubMed ID: 22452616
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous devices for stroke prevention.
Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
[TBL] [Abstract][Full Text] [Related]
12. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
Landmesser U; Holmes DR
Eur Heart J; 2012 Mar; 33(6):698-704. PubMed ID: 22041550
[TBL] [Abstract][Full Text] [Related]
13. Identifying future research priorities using value of information analyses: left atrial appendage occlusion devices in atrial fibrillation.
Micieli A; Bennell MC; Pham B; Krahn M; Singh SM; Wijeysundera HC
J Am Heart Assoc; 2014 Sep; 3(5):e001031. PubMed ID: 25227405
[TBL] [Abstract][Full Text] [Related]
14. Nonpharmacologic stroke prevention in atrial fibrillation.
Onalan O; Lashevsky I; Hamad A; Crystal E
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):619-33. PubMed ID: 16076273
[TBL] [Abstract][Full Text] [Related]
15. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
[TBL] [Abstract][Full Text] [Related]
16. Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion.
Lewalter T; Kanagaratnam P; Schmidt B; Rosenqvist M; Nielsen-Kudsk JE; Ibrahim R; Albers BA; Camm AJ
Europace; 2014 May; 16(5):626-30. PubMed ID: 24798956
[TBL] [Abstract][Full Text] [Related]
17. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
Garcia DA
Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation and stroke management: present and future.
Holmes DR
Semin Neurol; 2010 Nov; 30(5):528-36. PubMed ID: 21207345
[TBL] [Abstract][Full Text] [Related]
19. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
20. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
Le D; Morelli R; Badhwar N; Lee RJ
Expert Rev Cardiovasc Ther; 2015; 13(8):907-14. PubMed ID: 26070218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
